ReviewWorld journal of gastroenterology2006
Causal role of Helicobacter pylori infection in gastric cancer.
Review in World journal of gastroenterology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 44 citations in OpenAlex.
- Gastric Cancer: Pathobiology and Therapeutics.MedComm · 2026Review
- Association between the Dietary Inflammatory Index and Gastric Disease Risk: Findings from a Korean Population-Based Cohort Study.Nutrients · 2022Article
- Cancer prevention from the perspective of global cancer burden patterns.Journal of thoracic disease · 2017Article
- Gastric Adenocarcinoma: A Multimodal Approach.Frontiers in surgery · 2017Review
- Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone.The Journal of antibiotics · 2016Article
- Helicobacter pylori and neurological diseases: Married by the laws of inflammation.World journal of gastrointestinal pathophysiology · 2014Review
- Hematologic manifestations of Helicobacter pylori infection.World journal of gastroenterology · 2014Review
- Nutrition deficiency increases the risk of stomach cancer mortality.BMC cancer · 2012Article
- Clinical implications and characteristics of factor forkhead box protein 3 in gastric cancer.Experimental and therapeutic medicine · 2011Article
- Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma.Digestive diseases and sciences · 2008Article
- Genomic methylation: a tool for typing Helicobacter pylori isolates.Applied and environmental microbiology · 2007Article
- [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].Der Internist · 2006Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is the second most frequent cancer in the world, accounting for a large proportion of all cancer cases in Asia, Latin America, and some countries in Europe. Helicobacter pylori (H pylori) is regarded as playing a specific role in the development of atrophic gastritis, which represents the most recognized pathway in multistep intestinal-type gastric carcinogenesis. Recent studies suggest that a combination of host genetic factors, bacterial virulence factors, and environmental and lifestyle factors determine the severity of gastric damage and the eventual clinical outcome of H pylori infection. The seminal discovery of H pylori as the leading cause of gastric cancer should lead to effective eradication strategies. Prevention of gastric cancer requires better screening strategies to identify candidates for eradication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.